1. Introduction Epilepsy remains one of the most common neurological disorders worldwide, with a global impact of 65 million people (Beghi, 2020; Kanner and Bicchi, 2022). It is characterized by spontaneous recurrent seizures, and since there is no cure, the primary focus in treating epilepsy is to reduce seizures, often via anti-seizure medications (ASMs). When two tolerated and appropriately prescribed ASMs fail to achieve seizure freedom, the patient is deemed drug-resistant.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile